Microscopy from Scientific Research

Immunofluorescence labeling with various markers (ARHGAP12, ARHGAP29, beta-catenin, and CD44) of U251 cells treated with the GSK-3 inhibitor BIO. ICG001 and inhibitor combination reveals that ARHGAP12 and ARHGAP29 protein levels are altered after treatment with BIO and not affected by treatment with ICG001 alone or the combination treatment (n= 3/group). Scale bar: 200 um.

DOI